ArticleBritish journal of pharmacology2001

Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.

S D Katugampola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.